Pharmafile Logo
Pharmafocus logo
Advanced Search

IPEC Americas takes aim at atypical visible particles

March 4, 2013
Manufacturing and Production AVP, IPEC Americas

The industry body representing excipient users and suppliers in the US has set up a working group to tackle the …

News

Risk-assessment for excipients: guideline out for comment

March 4, 2013
Manufacturing and Production GMP, risk

The European Commission has published its long-awaited risk-assessment guideline for determining the level of Good Manufacturing Practice (GMP) needed for …

News

EU approval for Ilaris

March 4, 2013
Sales and Marketing Ilaris, Novartis

Novartis’ Ilaris has become the first biologic approved by the European Commission to treat patients suffering acute gouty arthritis attacks …

News
sanofi_hq_reception_close

Zaltrap launched in UK

March 4, 2013
Sales and Marketing Sanofi, Zaltrap

Sanofi and Regeneron Pharmaceuticals’ bowel cancer drug Zaltrap has been launched in the UK today. Zaltrap (aflibercept) will be used …

News

Boehringer targets AML

March 1, 2013
Research and Development, Sales and Marketing AML, Boehringer

Boehringer Ingelheim is to begin a pivotal trial of its investigative treatment volasertib in patients with acute myeloid leukaemia (AML). …

News

Lundbeck booze pill for EU

March 1, 2013
Sales and Marketing Lundbeck, alcohol, selincro

Lundbeck’s novel pill Selincro has been given European marketing authorisation to help patients with a drink problem to cut down. …

News
screen_shot_2013-02-28_at_14

RSA welcomes pan-European consultant

February 28, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing rsa

Life sciences executive search and interim management firm RSA has announced that Dr Theo de Roij has joined the pan-European …

Appointment
Eliquis image

Eliquis approved by NICE

February 28, 2013
Sales and Marketing BMS, Eliquis, NICE, Pfizer

In a move which will cheer Bristol-Myers Squibb and Pfizer, NICE has recommended oral blood-thinner Eliquis for use on the …

News
ABPI image

ABPI moves to improve compliance

February 28, 2013
Sales and Marketing ABPI, NHS, alltrials, goldaccre, whiehead

The ABPI has fired its latest salvo in the clinical trial transparency debate by announcing it will appoint a new …

News
UCB image

UCB warns of data ‘voyeurism’

February 27, 2013
Research and Development, Sales and Marketing EFPIA, UCB, VBP, transparancy

UCB chief executive Roch Doliveux has attacked the idea of making all clinical trial data publicly available, saying it could …

News
Roche image

Roche increases data access

February 27, 2013
Research and Development, Sales and Marketing ABPI, BMJ, Goldacre, Roche

Roche has launched a new process designed to enable greater access to its clinical trial data for researchers from outside …

News
annadixon

The King’s Fund’s Anna Dixon joins Department of Health

February 27, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dixon, NHS, king's fund

Director of Policy at The King’s Fund Dr Anna Dixon will be joining the Department of Health in early May …

Appointment
bad pharma image

Ben Goldacre versus Stephen Whitehead – PharmaTimes Debate

February 27, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BMJ, Bad pharma, Cochrane, Goldacre, Whitehead

In the end, the ‘head to head’ between the UK’s most high profile critic of the pharma industry and ABPI …

Feature
Merck image

Merck suffers brain cancer reverse

February 26, 2013
Sales and Marketing Merck, cilengitide

Merck’s oncology programme has suffered a setback as a Phase III trial of its investigational integrin inhibitor cilengitide failed in …

News
Omontys image

Probe launched as deaths prompt Omontys recall

February 26, 2013
Manufacturing and Production Affymax, Takeda, omontys, recall

Reports of three fatal reactions linked to administration of Takeda and Affymax’ Omontys anaemia treatment have led to a recall …

News
elan image

Elan sceptical of Royalty

February 26, 2013
Sales and Marketing Elan, FDA, Tysabri, royalty pharma

Elan Corporation has poured tepid water on private equity firm Royalty Pharma’s putative offer this week for the Irish biotech …

News

Pharma manufacturing news in brief

February 26, 2013
Manufacturing and Production Baxter International, Bone Therapeutic, DSM Pharmaceutical Products and Chemtrix, Sovereign Pharmaceutical

Sovereign Pharma rapped by FDA, facility updates from Bone Therapeutics, Baxter and SHL, plus a continuous processing alliance between DSM …

News
GSK image

Abbott, GSK cut staff at Irish facilities

February 26, 2013
Manufacturing and Production Abbottt, GSK, Ireland

GlaxoSmithKline and Abbott have both announced job cuts at their facilities in Ireland in a blow to the country’s pharmaceutical …

News

Continuous processing production line set up in Finland

February 25, 2013
Manufacturing and Production Finland, PROMIS

A specialist centre in Finland providing expertise in the continuous processing of pharmaceuticals, first envisaged in 2008, opened its doors …

News
screen_shot_2013-02-25_at_16

Pharmalink Consulting appoints five consultants

February 25, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmalink Consulting

Regulatory affairs firm Pharmalink Consulting has announced the appointment and promotion of five consultants at their offices in the UK, …

Appointment
The Gateway to Local Adoption Series

Latest content

IsomAb appoints Philip Brainin as CEO

March 19, 2026

Naobios partners with SGS to manufacture RSV challenge agent

March 19, 2026

Qlaris Bio appoints Fred Guerard as President and CEO

March 18, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

March 18, 2026

AEON Biopharma appoints John Bencich as CFO

March 17, 2026